A case of biliary tract infection with Streptococcus cristatus bacteremia
Abstract
Background: Streptococcus cristatus is an oral commensal organism belonging to the viridans group streptococci. Although generally nonpathogenic, recent reports have highlighted its potential to cause invasive infections. However, gastrointestinal infections due to this organism have not been previously documented. We report the first case of a biliary tract infection with S. cristatus bacteremia, highlighting its clinical relevance.
Case presentation: A 74-year-old Japanese man with hypertension and diabetes mellitus presented with severe epigastric pain and vomiting. Contrast-enhanced computed tomography confirmed choledocholithiasis, revealing common bile duct dilatation with an 8-mm stone near the ampulla of Vater. Blood cultures obtained on admission grew gram-positive cocci in chains, later identified as S. cristatus by 16S rRNA gene sequencing. The isolate was susceptible to beta-lactam antibiotics. Intravenous cefmetazole was administered for 6 days. Endoscopic retrograde cholangiopancreatography with sphincterotomy was performed on hospital days 2 and 5, achieving biliary drainage and stone removal. The patient recovered uneventfully and was discharged without sequelae on day 10.
Conclusions: This case represents the first documented biliary tract infection associated with S. cristatus bacteremia. Accurate species-level identification is critical, as it helps recognize the pathogenic potential of organisms traditionally considered commensal.
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross-sectional, population-based study
- Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China
- The Role of the NLR and PLR in Urinary Tract Infection
- Threat of Antimicrobial Resistance among Pilgrims with Infectious Diseases during Hajj: Lessons Learnt from COVID-19 Pandemic
- Leclercia adecarboxylata urinary tract infection in a patient with bladder cancer and recurrent hematuria
- A Case Series of Staphylococcus lugdunensis Infection in Cancer Patients at an Academic Cancer Institute in the United States
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.